174 related articles for article (PubMed ID: 20120531)
1. Impact of hemoglobin concentration on plasma B-type natriuretic peptide level and left ventricle echocardiographics characteristics in chronic kidney disease patients.
Rasić S; Hadzović-Dzuvo A; Tomić M; Uncanin S; Corić S
Coll Antropol; 2009 Dec; 33 Suppl 2():141-4. PubMed ID: 20120531
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between B-type natriuretic peptide plasma level and left ventricular function in patients with chronic kidney disease on different type of treatment].
Rasić S; Hadzovic-Dzuvo A; Rebić D; Dzemidzić J; Bilal F; Mataradzija A
Acta Med Croatica; 2008; 62 Suppl 1():7-11. PubMed ID: 18578326
[TBL] [Abstract][Full Text] [Related]
3. [B-type natriuretic peptide as a marker of cardiac dysfunction in children with chronic kidney disease].
Drożdż T; Kwinta P; Kordon Z; Sztefko K; Rudziński A; Zachwieja K; Miklaszewska M; Czarnecka D; Drożdż D
Pol Merkur Lekarski; 2018 Apr; 44(262):171-176. PubMed ID: 29775443
[TBL] [Abstract][Full Text] [Related]
4. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy.
Vickery S; Price CP; John RI; Abbas NA; Webb MC; Kempson ME; Lamb EJ
Am J Kidney Dis; 2005 Oct; 46(4):610-20. PubMed ID: 16183415
[TBL] [Abstract][Full Text] [Related]
5. Effect of anemia correction on left ventricular hypertrophy in patients with modestly high hemoglobin level and chronic kidney disease .
Akaishi M; Hiroe M; Hada Y; Suzuki M; Tsubakihara Y; Akizawa T;
J Cardiol; 2013 Oct; 62(4):249-56. PubMed ID: 23787155
[TBL] [Abstract][Full Text] [Related]
6. [Relationship of brain natriuretic peptide to renal function and left ventricular hypertrophy in patients with chronic kidney disease].
Zhou WY; Ni ZH; Gu LY; Fang W; Wang Q; Mou S; Cao LO; Yu ZZ; Qian JQ
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3284-7. PubMed ID: 18396626
[TBL] [Abstract][Full Text] [Related]
7. Effects of hemoglobin concentration and creatinine clearance in pro-B-type natriuretic peptide-based left ventricular filling pressure prediction in patients with preserved left ventricular systolic function.
Choi EY; Ha JW; Joung B; Ko YG; Choi D; Rim SJ; Jang Y; Chung N; Shim WH; Cho SY
Am J Cardiol; 2008 Feb; 101(3):364-9. PubMed ID: 18237601
[TBL] [Abstract][Full Text] [Related]
8. Brain natriuretic peptide as a marker of left ventricular hypertrophy in patients with aortic stenosis.
Orlowska-Baranowska E; Baranowski R; Greszata L; Stepinska J
J Heart Valve Dis; 2008 Nov; 17(6):598-605. PubMed ID: 19137789
[TBL] [Abstract][Full Text] [Related]
9. Association between C-reactive protein levels and N-terminal pro-B-type natriuretic peptide in pre-dialysis patients.
Ortega O; Gallar P; Muñoz M; Rodríguez I; Carreño A; Ortiz M; Molina A; Oliet A; Lozano L; Vigil A
Nephron Clin Pract; 2004; 97(4):c125-30. PubMed ID: 15331941
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor is associated to left ventricular mass index, anemia and low values of transferrin saturation.
Eser B; Yayar O; Buyukbakkal M; Erdogan B; Ercan Z; Merhametsiz O; Haspulat A; Oğuz EG; Dogan İ; Canbakan B; Ayli MD
Nefrologia; 2015; 35(5):465-72. PubMed ID: 26394828
[TBL] [Abstract][Full Text] [Related]
11. Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease--a prospective observational study.
Peiskerová M; Kalousová M; Danzig V; Míková B; Hodková M; Němeček E; Bani-Hani A; Ambrož D; Benáková H; Linhart A; Zima T; Tesař V
BMC Nephrol; 2013 Jul; 14():142. PubMed ID: 23844967
[TBL] [Abstract][Full Text] [Related]
12. Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography.
Matsumoto M; Io H; Furukawa M; Okumura K; Masuda A; Seto T; Takagi M; Sato M; Nagahama L; Omote K; Hisada A; Horikoshi S; Tomino Y
J Nephrol; 2012; 25(5):794-801. PubMed ID: 22241636
[TBL] [Abstract][Full Text] [Related]
13. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L
Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
[TBL] [Abstract][Full Text] [Related]
14. Serum cystatin C level is associated with left atrial enlargement, left ventricular hypertrophy and impaired left ventricular relaxation in patients with stage 2 or 3 chronic kidney disease.
Sakuragi S; Ichikawa K; Yamada K; Tanimoto M; Miki T; Otsuka H; Yamamoto K; Kawamoto K; Katayama Y; Tanakaya M; Ito H
Int J Cardiol; 2015; 190():287-92. PubMed ID: 25932809
[TBL] [Abstract][Full Text] [Related]
15. Anemia and left ventricular hypertrophy with renal function decline and cardiovascular events in chronic kidney disease.
Chang JM; Chen SC; Huang JC; Su HM; Chen HC
Am J Med Sci; 2014 Mar; 347(3):183-9. PubMed ID: 23426086
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of plasma brain natriuretic peptide, urea nitrogen, and creatinine in outpatients >70 years of age with heart failure.
Feola M; Aspromonte N; Canali C; Ceci V; Giovinazzo P; Milani L; Quarta G; Ricci R; Scardovi AB; Uslenghi E; Valle R
Am J Cardiol; 2005 Sep; 96(5):705-9. PubMed ID: 16125500
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of B-type natriuretic peptide for assessment of left ventricular function in patients with chronic kidney disease.
Soleimani A; Nasiri O; Nikoueinejad H; Mianehsaz E; Yousefzade M; Foroozanfard F; Tabatabaizadeh M; Moraveji SA; Rajali M
Iran J Kidney Dis; 2011 Jul; 5(4):242-7. PubMed ID: 21725181
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic potential of circulating natriuretic peptides in chronic kidney disease.
Mark PB; Stewart GA; Gansevoort RT; Petrie CJ; McDonagh TA; Dargie HJ; Rodger RS; Jardine AG
Nephrol Dial Transplant; 2006 Feb; 21(2):402-10. PubMed ID: 16221702
[TBL] [Abstract][Full Text] [Related]
20. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.
Cataliotti A; Malatino LS; Jougasaki M; Zoccali C; Castellino P; Giacone G; Bellanuova I; Tripepi R; Seminara G; Parlongo S; Stancanelli B; Bonanno G; Fatuzzo P; Rapisarda F; Belluardo P; Signorelli SS; Heublein DM; Lainchbury JG; Leskinen HK; Bailey KR; Redfield MM; Burnett JC
Mayo Clin Proc; 2001 Nov; 76(11):1111-9. PubMed ID: 11702899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
